TENORMIN

This brand name is authorized in Austria, Australia, Canada, Cyprus, Germany, Ecuador, Spain, Hong Kong, Italy, Japan, Malta, Mexico, Nigeria, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug TENORMIN contains one active pharmaceutical ingredient (API):

1 Atenolol
UNII 50VV3VW0TI - ATENOLOL

Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects.

Read about Atenolol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
TENORMIN Tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TENORMIN Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C07AB03 Atenolol C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1081X
Country: CA Health Products and Food Branch Identifier(s): 02039532, 02039540
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 02477686
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 361630812, 362951112
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 56777, 56967
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 13308, 27862
Country: HK Department of Health Drug Office Identifier(s): 06812, 17873
Country: IT Agenzia del Farmaco Identifier(s): 024016038
Country: JP 医薬品医療機器総合機構 Identifier(s): 2123011F1155, 2123011F2437
Country: MT Medicines Authority Identifier(s): AA565/41701
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 88870
Country: NG Registered Drug Product Database Identifier(s): 04-0336
Country: SG Health Sciences Authority Identifier(s): 00348P, 08669P
Country: US FDA, National Drug Code Identifier(s): 52427-429, 52427-430, 52427-431
Country: ZA Health Products Regulatory Authority Identifier(s): 27/5.2/0251, J/5.2/0120, P/5.2/174, P/5.2/268

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.